What is the management and treatment of Gerbode fistula?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management and Treatment of Gerbode Fistula

Gerbode defect requires surgical repair in symptomatic patients, with percutaneous closure as an alternative in high-risk surgical candidates, preceded by aggressive treatment of any underlying infective endocarditis with prolonged intravenous antibiotics.

Definition and Clinical Context

A Gerbode defect is an abnormal communication between the left ventricle and right atrium, creating a left-to-right shunt 1, 2. While most cases are congenital, acquired defects occur as complications of:

  • Infective endocarditis (particularly prosthetic valve endocarditis) 1, 3
  • Cardiac surgery (especially aortic or mitral valve replacement) 2, 4
  • Myocardial infarction 2
  • Invasive percutaneous procedures 5

Diagnostic Approach

Echocardiography is essential to identify the high-velocity jet from left ventricle to right atrium, assess valve function, and detect associated complications 1, 3. Specific findings to evaluate include:

  • Presence and location of the ventricular-atrial communication 4
  • Degree of left-to-right shunting 2
  • Associated valve pathology (dehiscence, vegetations, regurgitation) 1, 3
  • Evidence of heart failure or hemodynamic compromise 1, 2

Blood cultures must be obtained in all cases to rule out infective endocarditis, as this fundamentally changes management 1.

Treatment Algorithm

Step 1: Manage Active Infection

If infective endocarditis is confirmed:

  • Initiate prolonged intravenous antibiotics (minimum 6 weeks) targeting the identified organism 6, 1
  • Treat as subacute bacterial endocarditis with appropriate antimicrobial coverage 6
  • Stabilize hemodynamics and manage heart failure medically before definitive repair 1, 2

Step 2: Definitive Repair Strategy

For surgical candidates:

  • Surgical repair is the gold standard, involving patch closure of the defect with concurrent management of any valve pathology 3, 4
  • Surgery should address all components: valve replacement/repair, Gerbode defect closure, and any left ventricular-aortic discontinuity if present 3
  • Timing: Perform after initial stabilization and infection control, but before development of irreversible complications 1

For high-risk surgical patients:

  • Percutaneous device closure may be considered when surgical risk is prohibitive 2
  • This approach is feasible if the defect anatomy is suitable for transcatheter closure 2
  • Reserve this for patients with resistant heart failure who cannot tolerate open surgery 2

Step 3: Management of Complications

If septic emboli occur:

  • Surgical excision of the fistula is mandatory rather than medical management alone 6
  • This represents a surgical emergency requiring urgent intervention 6

If left ventricular-aortic discontinuity is present:

  • Requires extensive reconstructive surgery with xenopericardial patch reconstruction of the left ventricular outflow tract 3
  • Supra-annular valve replacement may be necessary 3

Critical Pitfalls to Avoid

  • Missing the diagnosis on initial echocardiography, especially in post-cardiac surgery patients—actively look for abnormal flow from left ventricle to right atrium 1
  • Delaying surgical intervention in the presence of septic emboli or hemodynamic instability 6, 1
  • Attempting percutaneous closure in the setting of active infection—infection must be controlled first 1, 2
  • Inadequate antibiotic duration for associated endocarditis—full 6-week course is required 6

Prognosis

Outcomes depend heavily on:

  • Prompt recognition and treatment of the defect 1
  • Successful infection control when endocarditis is present 1
  • Completeness of surgical repair addressing all anatomic abnormalities 3

Delayed diagnosis or treatment can result in progressive heart failure, recurrent embolic events, and death 1.

References

Research

The Gerbode defect: a case series.

European heart journal. Case reports, 2021

Research

Gerbode defect and left ventricular-aortic discontinuity in prosthetic valve endocarditis.

Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs, 2020

Research

Congenital Gerbode defect in an adult patient: report of an extremely rare case.

Archivos peruanos de cardiologia y cirugia cardiovascular, 2023

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.